Basic HTML Version
120
SCIENTIFIC REPORT 2012
J Rheumatol
. 2012 Dec;39(12):2294-2302.
Influence of the IL6 Gene in Susceptibility to
Systemic Sclerosis
. Cénit MC, Simeón CP, Vonk MC, Callejas-Rubio JL, Espinosa G,
Carrera P, Blanco FJ, Narvaez J, Tolosa C, Román-Ivorra JA, Gómez-García I, García-
Hernández FJ, Gallego M, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P,
López-Longo FJ, González-Gay MA; The Spanish Scleroderma Group, Hesselstrand R,
Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R, Fonseca C, Denton C,
Nordin A, Palm O, van Laar JM, Hunzelmann N, Distler JH, Kreuter A, Herrick A, Worthington J,
Koeleman BP, Radstake TR, Martín J.
PLoS One
. 2012; 7 (9): e44679.
Double stranded sperm DNA breaks, measured by Comet
assay, are associated with unexplained recurrent miscarriage in couples without a
female factor
. Ribas-Maynou J, García-Peiró A, Fernandez-Encinas A, Amengual MJ, Prada
E, Cortés P, Navarro J, Benet J.
Breath Nothing
. 2012 Dec 11; 13: 113.
Specific IgA and metalloproteinase activity in bronchi
secretions from stable chronic obstructive pulmonary disease patients colonized by
Haemophilus influenzae
. Millares L, Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Monsó
And PAC-COPD Study Group.
Scand J Rheumatol
. 2012 Feb;41(1):10-4.
The C677T polymorphism in the MTHFR gene is
associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population
.
Cáliz R, del Amo J, Balsa A, Blanco F, Silva L, Sanmarti R, Martínez FG, Collado MD, Ramirez
Mdel C, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Andreu JL, Graell E, Simon L,
Martínez A, Mulero J.
World J Gastroenterol
. 2012 May 7; 18 (17): 2084-91.
Rifaximin, but not growth factor 1,
reduces brain edema in cirrhotic rats
. Odena G, Miquel M, Serafín A, Galan A, Morillas R,
Planas R, Bartolí R.
Inflammation, immunology and metabolism Clinical and translational research
Projects
Title:
Phase III study, randomized, double-blind, with parallel groups, 24 weeks for
to evaluate the efficacy and safety of oral administration, twice daily, of empagliflozin +
metformin compared to the individual components, empagliflozin or metformin in
naive patients with type 2 diabetes mellitus.
District Attorney:
Boehringer Ingelheim España SA
Principal Investigator:
Jaume Arroyo Bros.